CD9 and cancer: Recent findings have identified CD9-positive exosome subpopulations as progressive markers for lung cancer in HIV-positive individuals, exhibiting notably lower concentrations in the plasma of HIV-positive lung cancer patients than in that of HIV-positive individuals without cancer [41].